½ÃÀ庸°í¼­
»óǰÄÚµå
1824363

¼¼°èÀÇ ³úÁøÅÁ ½ÃÀå º¸°í¼­(2025³â)

Concussion Global Market Report 2025

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: The Business Research Company | ÆäÀÌÁö Á¤º¸: ¿µ¹® 250 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

³úÁøÅÁ ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¼ö³â°£ ¾ÈÁ¤µÈ ¼ºÀåÀÌ Àü¸ÁµË´Ï´Ù. 2029³â¿¡´Â CAGR 4.8%¸¦ ³ªÅ¸³» 99¾ï ´Þ·¯·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹Ãø ±â°£ÀÇ ¼ºÀåÀº ½ºÆ÷Ã÷ÀÇ ¾ÈÀü¼º¿¡ ´ëÇÑ Áö¼ÓÀûÀÎ ÁÖ¸ñ, Ä¡·á¿¡ À־ÀÇ ¿¬±¸°³¹ß, ³úÁøÅÁ ÇÁ·ÎÅäÄÝÀÇ Ã¤¿ë Áõ°¡, °øÁßÀ§»ý¿¡ ´ëÇÑ °ü½ÉÀÇ ³ô¾ÆÁü, ÀÇ·á°è¿Í ½ºÆ÷Ã÷°èÀÇ Á¦ÈÞ µî¿¡ ±âÀÎÇÏ´Â °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¿¹Ãø ±â°£ Áß ÁÖ¿ä µ¿ÇâÀ¸·Î´Â ¿ø°Ý ³úÁøÅÁ ¼­ºñ½º¿Í ¿ø°Ý ¸ð´ÏÅ͸µ, ³úÁøÅÁ ¿¹¹æÀ» À§ÇÑ ±³À° ÀÌ´Ï¼ÅÆ¼ºê, Àå±âÀû ¿µÇâ°ú ¸¸¼º ¿Ü»ó¼º ³úÁõ(CTE)¿¡ °üÇÑ ¿¬±¸, ½ºÆ÷Ã÷ Á¶Á÷¿¡ ³úÁøÅÁ ÇÁ·ÎÅäÄÝ µµÀÔ, ½Å°æº¸È£ ¿ä¹ý °³¹ß, ³úÁøÅÁ °ü¸®¸¦ À§ÇÑ ¹ý±ÔÁ¦ µîÀÌ ÀÖ½À´Ï´Ù.

ÇâÈÄ 5³â°£ÀÇ ¼ºÀå·ü 4.8%¶ó°í ÇÏ´Â ¿¹ÃøÀº ÀüȸÀÇ ¿¹ÃøÀ¸·ÎºÎÅÍ 0.2%ÀÇ ¼ÒÆøÀÇ °¨¼Ò¸¦ ¹Ý¿µÇϰí ÀÖ½À´Ï´Ù. ÀÌ °¨¼Ò´Â ÁÖ·Î ¹Ì±¹°ú ´Ù¸¥ ±¹°¡ °£ÀÇ °ü¼¼ÀÇ ¿µÇâ ¶§¹®ÀÔ´Ï´Ù. °ü¼¼ À庮Àº ½º¿þµ§°ú ³×´ú¶õµå¿¡¼­ °ø±ÞµÇ´Â °í±Þ ³úÁøÅÁ Æò°¡ ÀåºñÀÇ ºñ¿ëÀ» ³ôÀ̰í Á¤È®ÇÑ Áø´ÜÀ» ´ÊÃß°í ½Å°æ°úÀÇ ºñ¿ëÀ» ³ô¿© ¹Ì±¹ ½ÃÀåÀ» ¹æÇØÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¶ÇÇÑ »óÈ£°ü¼¼¿Í ¹«¿ªÀÇ ±äÀå°ú ÇѰè Áõ°¡·Î ÀÎÇÑ ¼¼°è°æÁ¦¿Í ¹«¿ª¿¡ ´ëÇÑ ¾Ç¿µÇâÀ¸·Î ÀÎÇØ ±× ¿µÇâÀÌ ´õ¿í ±¤¹üÀ§ÇÏ°Ô µË´Ï´Ù.

³úÁøÅÁ ½ÃÀå ¼ºÀåÀº ³ú ¼Õ»óÀÇ À¯º´·ü Áõ°¡¿¡ ÀÇÇØ ÃËÁøµÉ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ³ú ¼Õ»óÀº ³ú¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ´Ù¾çÇÑ ¼Õ»óÀ» Æ÷ÇÔÇϸç, ±× °á°ú ½ÅüÀû, ÀÎÁöÀû, °¨Á¤ÀûÀ¸·Î ´Ù¾çÇÑ Àå¾Ö°¡ ¹ß»ýÇÕ´Ï´Ù. ³úÁøÅÁÀÇ Àû½Ã ¹× ÀûÀýÇÑ Ä¡·á´Â ³ú °ü·Ã ¼Õ»óÀ¸·Î ÀÎÇÑ ³úÀÇ Àüü °Ç°­¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» ÁÙÀ̱â À§ÇØ ¸Å¿ì Áß¿äÇÕ´Ï´Ù. À̸¦ À§Çؼ­´Â ½ÅüÀû¡¤ÀÎÁöÀû ¾ÈÁ¤, Áõ»ó °ü¸®, Ȱµ¿À¸·ÎÀÇ ´Ü°èÀû º¹±Í µîÀÇ ½ÇõÀÌ ÇÊ¿äÇÕ´Ï´Ù. ±³Åë»ç°í Áõ°¡µµ ³ú¼Õ»ó ¹ß»ý·üÀ» ³ôÀ̰í ÀÖ½À´Ï´Ù. ¹Ì±¹ ¹Ì»ý¹°°øÇÐÁ¤º¸¼¾ÅÍ(NCBI)ÀÇ 2023³â 1¿ù ±â»ç¿¡ µû¸£¸é ¹Ì±¹¿¡¼­´Â ¿¬°£ ÃßÁ¤ 170¸¸¸íÀÌ ¿Ü»ó¼º ³ú ¼Õ»óÀ» °æÇèÇϰí ÀÖÀ¸¸ç, 15-19¼¼¿Í 65¼¼ ÀÌ»óÀÇ ³ëÀÎÀÌ °¡Àå ³ôÀº À§Çè¿¡ Á÷¸éÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¹Ì±¹¿¡¼­´Â ³ú¿Í ô¼öÀÇ ¿ø¹ß¼º ¾Ç¼º Á¾¾çÀÌ ¼öõ ¸í¿¡ ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±× °á°ú, ³ú¼Õ»ó À¯º´·ü Áõ°¡°¡ ³úÁøÅÁ ½ÃÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀÌ µÇ°í ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå : ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ¹«¿ªÀüÀï°ú °ü¼¼, ±×¸®°í Äڷγª ¹× ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

  • ¼¼°èÀÇ ³úÁøÅÁ : PESTEL ºÐ¼®(Á¤Ä¡, »çȸ, ±â¼ú, ȯ°æ, ¹ýÀû ¿äÀÎ, ¼ºÀå ÃËÁø¿äÀΰú ¾ïÁ¦¿äÀÎ)
  • ÃÖÁ¾ ÀÌ¿ë »ê¾÷ÀÇ ºÐ¼®
  • ¼¼°èÀÇ ³úÁøÅÁ ½ÃÀå : ¼ºÀå·ü ºÐ¼®
  • ¼¼°èÀÇ ³úÁøÅÁ ½ÃÀå ½ÇÀû : ±Ô¸ð¿Í ¼ºÀå(2019-2024³â)
  • ¼¼°èÀÇ ³úÁøÅÁ ½ÃÀå ¿¹Ãø : ±Ô¸ð¿Í ¼ºÀå(2024-2029³â, 2034³â)
  • ¼¼°èÀÇ ³úÁøÅÁ : Àüü ½ÃÀå ±Ô¸ð(TAM)

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

  • ¼¼°èÀÇ ³úÁøÅÁ ½ÃÀå : Æò°¡º°, ºÐ¼®°ú ¿¹Ãø(2019-2024³â, 2024-2029³â, 2034³â)
  • Áø´Ü
  • Ä¡·á
  • ¼¼°èÀÇ ³úÁøÅÁ ½ÃÀå : ±â±âº°, ºÐ¼®°ú ¿¹Ãø(2019-2024³â, 2024-2029³â, 2034³â)
  • ¿µ»ó ÀåÄ¡
  • ÀÚ±â°ø¸í¿µ»ó(MRI) ÀåÄ¡
  • X¼±
  • ÄÄÇ»ÅÍ ´ÜÃþÃÔ¿µ
  • ¸ð´ÏÅ͸µ ÀåÄ¡
  • ±âŸ ÀåÄ¡
  • ¼¼°èÀÇ ³úÁøÅÁ ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°, ºÐ¼®°ú ¿¹Ãø(2019-2024³â, 2024-2029³â, 2034³â)
  • º´¿ø ¹× Áø·á¼Ò
  • Áø´Ü ¼¾ÅÍ
  • ÀÇ·á Ä·ÇÁ
  • ±âŸ ÃÖÁ¾ »ç¿ëÀÚ
  • ¼¼°èÀÇ ³úÁøÅÁ ½ÃÀå : Áø´Ü À¯Çüº°, ºÐ¼®°ú ¿¹Ãø(2019-2024³â, 2024-2029³â, 2034³â)
  • ÀÓ»ó Æò°¡
  • ¿µ»ó ±â¹ý
  • ¼¼°èÀÇ ³úÁøÅÁ ½ÃÀå : Ä¡·á À¯Çüº°, ºÐ¼®°ú ¿¹Ãø(2019-2024³â, 2024-2029³â, 2034³â)
  • ¾à¸®ÇÐÀû Ä¡·á
  • ÀÎÁö ÀçȰ
  • ¹°¸® Ä¡·á

Á¦7Àå Áö¿ªº°/±¹°¡º° ºÐ¼®

  • ¼¼°èÀÇ ³úÁøÅÁ ½ÃÀå : Áö¿ªº°, ºÐ¼®°ú ¿¹Ãø(2019-2024³â, 2024-2029³â, 2034³â)
  • ¼¼°èÀÇ ³úÁøÅÁ ½ÃÀå : ±¹°¡º°, ºÐ¼®°ú ¿¹Ãø(2019-2024³â, 2024-2029³â, 2034³â)

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ ÇÁ·ÎÆÄÀÏ

  • ³úÁøÅÁ ½ÃÀå : °æÀï ±¸µµ
  • ³úÁøÅÁ ½ÃÀå : ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • Pfizer Inc. : °³¿ä, Á¦Ç° ¹× ¼­ºñ½º, Àü·« ¹× À繫 ºÐ¼®
    • Novartis AG : °³¿ä, Á¦Ç° ¹× ¼­ºñ½º, Àü·« ¹× À繫 ºÐ¼®
    • Sanofi SA : °³¿ä, Á¦Ç° ¹× ¼­ºñ½º, Àü·« ¹× À繫 ºÐ¼®
    • Abbott Laboratories : °³¿ä, Á¦Ç° ¹× ¼­ºñ½º, Àü·« ¹× À繫 ºÐ¼®
    • Medtronic plc : °³¿ä, Á¦Ç° ¹× ¼­ºñ½º, Àü·« ¹× À繫 ºÐ¼®

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷ ¹× Çõ½Å ±â¾÷

  • Viatris Inc.
  • Zydus Lifesciences Ltd.
  • Integra LifeSciences Corporation
  • Nihon Kohden Corporation
  • Raumedic AG
  • Lupin Limited
  • NeuroPace Inc.
  • Compumedics Limited
  • NeuroLogica Corporation
  • Neural Analytics Inc.
  • NovaSignal Corp.
  • Back Bay Life Science Advisors
  • BrainScope Company Inc.
  • Neuro Kinetics Inc.
  • ImPACT Applications Inc.

Á¦32Àå ¼¼°è ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀåÀÇ ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

  • ³úÁøÅÁ ½ÃÀå(2029³â) : »õ·Î¿î ±âȸ¸¦ Á¦°øÇÏ´Â ±¹°¡
  • ³úÁøÅÁ ½ÃÀå(2029³â) : »õ·Î¿î ±âȸ¸¦ Á¦°øÇÏ´Â ºÎ¹®
  • ³úÁøÅÁ ½ÃÀå(2029³â) : ¼ºÀå Àü·«
    • ½ÃÀå µ¿Çâ¿¡ ±âÃÊÇÑ Àü·«
    • °æÀï Àü·«

Á¦36Àå ºÎ·Ï

KTH

A concussion refers to a form of traumatic brain injury (TBI) resulting from a sudden impact or force to the head or body, leading to the rapid movement of the brain within the skull. This condition can cause temporary impairment of brain function and disrupt normal neurological activities.

Concussion assessments primarily revolve around diagnosis and treatment. Diagnosis involves identifying the medical condition or injury through a comprehensive assessment of symptoms, medical history, and various diagnostic tests. These tests often include imaging tools such as magnetic resonance imaging (MRI), X-rays, computed tomography (CT), as well as monitoring devices and other diagnostic equipment. These assessments are utilized by a range of healthcare facilities such as hospitals, clinics, diagnostic centers, and medical camps to evaluate and manage concussions.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The concussion market research report is one of a series of new reports from The Business Research Company that provides concussion market statistics, including the concussion industry's global market size, regional shares, competitors with a concussion market share, detailed concussion market segments, market trends and opportunities, and any further data you may need to thrive in the concussion industry. This concussion market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The concussion market size has grown steadily in recent years. It will grow from $7.97 billion in 2024 to $8.2 billion in 2025 at a compound annual growth rate (CAGR) of 2.9%. The growth in the historic period can be attributed to increased awareness and education, sports participation and injuries, stringent sports regulations, advancements in diagnostic tools, and legal and ethical implications.

The concussion market size is expected to see steady growth in the next few years. It will grow to $9.9 billion in 2029 at a compound annual growth rate (CAGR) of 4.8%. The growth in the forecast period can be attributed to the continued focus on sports safety, research and development in treatment, increased adoption of concussion protocols, growing public health concerns, and collaboration between medical and sports communities. Major trends in the forecast period include teleconcussion services and remote monitoring, educational initiatives for concussion prevention, research on long-term effects and chronic traumatic encephalopathy (CTE), implementation of concussion protocols in sports organizations, development of neuroprotective therapies, legislation, and regulations for concussion management.

The forecast of 4.8% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. market by increasing the cost of advanced concussion assessment devices sourced from Sweden and the Netherlands, thereby delaying accurate diagnoses and elevating neurology department costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growth of the concussion market is anticipated to be propelled by an increase in the prevalence of brain injuries. Brain injuries encompass a range of damages affecting the brain, resulting in diverse physical, cognitive, and emotional impairments. Timely and appropriate treatment of concussions is crucial for mitigating the impact of brain-related injuries on overall brain health. This involves practices such as physical and cognitive rest, symptom management, and a gradual return to activities. The escalation in traffic accidents has also contributed to the higher incidence of brain injuries. According to a January 2023 article from the National Center for Biotechnology Information (NCBI), an estimated 1.7 million people in the United States experience traumatic brain injuries annually, with individuals aged 15 to 19 and seniors aged 65 and older facing the highest risk. Moreover, primary malignant tumors of the brain and spinal cord are expected to impact thousands of people in the US. Consequently, the increasing prevalence of brain injuries is a key driver of the concussion market.

The growth trajectory of the concussion market is further expected to be influenced by the rise in the prevalence of neurological diseases. Neurological diseases constitute a diverse range of medical conditions affecting the nervous system, encompassing the brain, spinal cord, and peripheral nerves. Traumatic brain injuries, often involving concussions, are significant contributors to the initiation, exacerbation, or complications of various neurological diseases such as chronic traumatic encephalopathy (CTE) or post-concussion syndrome. As of February 2023, the World Health Organization (WHO) reports that epilepsy, a neurological disease, affects approximately 5 million people globally. High-income countries witness 49 cases per 100,000 individuals, while low- and middle-income countries experience up to 139 cases per 100,000. The prevalence of neurological diseases, therefore, plays a pivotal role in driving the growth of the concussion market.

Product innovation stands out as a prominent trend shaping the landscape of the concussion market. Leading companies in this market are directing their efforts towards developing innovative products to enhance their diagnostic capabilities and maintain a competitive edge. One notable example is TecTraum Inc., a US-based medical device designer, and Nottingham-Spirk Design Associates Inc., a US-based product design firm, who collaborated to introduce pro2cool in May 2022. Recognized as the world's first point-of-care treatment for concussions, pro2cool is a groundbreaking noninvasive hypothermic treatment device. Engineered to alleviate the severity of concussion symptoms, it aims to expedite patients' recovery to their pre-injury baseline. The device achieves this by locally cooling the head and neck, thereby lowering blood temperature before it reaches the brain. Clinical investigations have shown promising results, indicating significant improvements in clinical outcomes when the brain is cooled within days following a concussion.

Major players are embracing strategic partnerships as a proactive approach to raise awareness about the gravity of concussions. Strategic partnerships involve companies leveraging each other's strengths and resources for mutual benefits and success. An illustrative instance of such collaboration is the partnership between Abbott Laboratories, a US-based medical device company, and the Brain Injury Association of America (BIAA), a US-based national organization. Formed in December 2022, this alliance aims to heighten awareness about the seriousness of concussions and emphasize the importance of seeking care for potential concussions. The coalition, comprising nearly twenty advocacy groups, addresses the alarming fact that more than half of individuals suspecting a concussion fail to seek medical evaluation. This strategic collaboration is positioned to play a crucial role in raising public consciousness about concussion-related issues.

In August 2023, Oxeia Biopharmaceuticals Inc., a clinical-stage biotech company based in the United States, successfully acquired SUN11031, a synthetic human ghrelin compound, from Kinemed Inc., another U.S.-based pharmaceutical research and development firm. The financial details of this transaction were not disclosed. This strategic acquisition by Oxeia Biopharmaceuticals aims to leverage SUN11031, which will be developed under the designation OXE103, as a potential treatment for concussions and acute neurotrauma.

Major companies operating in the concussion market include Pfizer Inc., Novartis AG, Sanofi SA, Abbott Laboratories, Medtronic plc, Viatris Inc., Zydus Lifesciences Ltd., Integra LifeSciences Corporation, Nihon Kohden Corporation, Raumedic AG, Lupin Limited, NeuroPace Inc., Compumedics Limited, NeuroLogica Corporation, Neural Analytics Inc., NovaSignal Corp., Back Bay Life Science Advisors, BrainScope Company Inc., Neuro Kinetics Inc., ImPACT Applications Inc., NanoDx Inc., Neuren Pharmaceuticals Limited, Advanced Brain Monitoring Inc., ElMindA Ltd., NeurOptics Inc., InfraScan Inc., Neuro Assessment Systems Inc., NeuroTrauma Sciences LLC, SyncThink Inc., Oxeia Biopharmaceuticals Inc., Oculogica Inc., Banyan Biomarkers Inc., Emotiv Inc., BioDirection Inc., Neurologic Wellness Institute

North America was the largest region in the concussion market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the concussion market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the concussion market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The concussion market consists of revenues earned by entities by providing concussion services such as consultations, diagnostic tests, imaging studies, CT scans, MRIs, and specialized diagnostic tests. The market value includes the value of related goods sold by the service provider or included within the service offering. The concussion market also includes sales of medications such as pain relievers, anti-nausea medication, or drugs targeting sleep disturbances or mood disorders. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Concussion Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on concussion market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for concussion ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The concussion market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Assessment: Diagnosis; Treatment
  • 2) By Device: Imaging Devices; Magnetic Resonance Imaging (MRI) Devices; X-Ray; Computed Tomography; Monitoring Devices; Other Devices
  • 3) By End User: Hospitals And Clinics; Diagnostic Centers; Medical Camps; Other End-Users
  • Subsegments:
  • 1) By Diagnosis: Clinical Assessments; Imaging Techniques
  • 2) By Treatment: Pharmacological Treatments; Cognitive Rehabilitation; Physical Therapy
  • Companies Mentioned: Pfizer Inc.; Novartis AG; Sanofi SA; Abbott Laboratories; Medtronic plc; Viatris Inc.; Zydus Lifesciences Ltd.; Integra LifeSciences Corporation; Nihon Kohden Corporation; Raumedic AG; Lupin Limited; NeuroPace Inc.; Compumedics Limited; NeuroLogica Corporation; Neural Analytics Inc.; NovaSignal Corp.; Back Bay Life Science Advisors; BrainScope Company Inc.; Neuro Kinetics Inc.; ImPACT Applications Inc.; NanoDx Inc.; Neuren Pharmaceuticals Limited; Advanced Brain Monitoring Inc.; ElMindA Ltd.; NeurOptics Inc.; InfraScan Inc.; Neuro Assessment Systems Inc.; NeuroTrauma Sciences LLC; SyncThink Inc.; Oxeia Biopharmaceuticals Inc.; Oculogica Inc.; Banyan Biomarkers Inc.; Emotiv Inc.; BioDirection Inc.; Neurologic Wellness Institute
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Concussion Market Characteristics

3. Concussion Market Trends And Strategies

4. Concussion Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Concussion Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Concussion PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Concussion Market Growth Rate Analysis
  • 5.4. Global Concussion Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Concussion Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Concussion Total Addressable Market (TAM)

6. Concussion Market Segmentation

  • 6.1. Global Concussion Market, Segmentation By Assessment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diagnosis
  • Treatment
  • 6.2. Global Concussion Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Imaging Devices
  • Magnetic Resonance Imaging (MRI) Devices
  • X-Ray
  • Computed Tomography
  • Monitoring Devices
  • Other Devices
  • 6.3. Global Concussion Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Clinics
  • Diagnostic Centers
  • Medical Camps
  • Other End-Users
  • 6.4. Global Concussion Market, Sub-Segmentation Of Diagnosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Clinical Assessments
  • Imaging Techniques
  • 6.5. Global Concussion Market, Sub-Segmentation Of Treatment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pharmacological Treatments
  • Cognitive Rehabilitation
  • Physical Therapy

7. Concussion Market Regional And Country Analysis

  • 7.1. Global Concussion Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Concussion Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Concussion Market

  • 8.1. Asia-Pacific Concussion Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Concussion Market, Segmentation By Assessment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Concussion Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Concussion Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Concussion Market

  • 9.1. China Concussion Market Overview
  • 9.2. China Concussion Market, Segmentation By Assessment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Concussion Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Concussion Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Concussion Market

  • 10.1. India Concussion Market, Segmentation By Assessment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Concussion Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Concussion Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Concussion Market

  • 11.1. Japan Concussion Market Overview
  • 11.2. Japan Concussion Market, Segmentation By Assessment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Concussion Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Concussion Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Concussion Market

  • 12.1. Australia Concussion Market, Segmentation By Assessment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Concussion Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Concussion Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Concussion Market

  • 13.1. Indonesia Concussion Market, Segmentation By Assessment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Concussion Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Concussion Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Concussion Market

  • 14.1. South Korea Concussion Market Overview
  • 14.2. South Korea Concussion Market, Segmentation By Assessment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Concussion Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Concussion Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Concussion Market

  • 15.1. Western Europe Concussion Market Overview
  • 15.2. Western Europe Concussion Market, Segmentation By Assessment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Concussion Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Concussion Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Concussion Market

  • 16.1. UK Concussion Market, Segmentation By Assessment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Concussion Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Concussion Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Concussion Market

  • 17.1. Germany Concussion Market, Segmentation By Assessment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Concussion Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Concussion Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Concussion Market

  • 18.1. France Concussion Market, Segmentation By Assessment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Concussion Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Concussion Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Concussion Market

  • 19.1. Italy Concussion Market, Segmentation By Assessment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Concussion Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Concussion Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Concussion Market

  • 20.1. Spain Concussion Market, Segmentation By Assessment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Concussion Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Concussion Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Concussion Market

  • 21.1. Eastern Europe Concussion Market Overview
  • 21.2. Eastern Europe Concussion Market, Segmentation By Assessment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Concussion Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Concussion Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Concussion Market

  • 22.1. Russia Concussion Market, Segmentation By Assessment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Concussion Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Concussion Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Concussion Market

  • 23.1. North America Concussion Market Overview
  • 23.2. North America Concussion Market, Segmentation By Assessment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Concussion Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Concussion Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Concussion Market

  • 24.1. USA Concussion Market Overview
  • 24.2. USA Concussion Market, Segmentation By Assessment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Concussion Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Concussion Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Concussion Market

  • 25.1. Canada Concussion Market Overview
  • 25.2. Canada Concussion Market, Segmentation By Assessment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Concussion Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Concussion Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Concussion Market

  • 26.1. South America Concussion Market Overview
  • 26.2. South America Concussion Market, Segmentation By Assessment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Concussion Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Concussion Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Concussion Market

  • 27.1. Brazil Concussion Market, Segmentation By Assessment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Concussion Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Concussion Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Concussion Market

  • 28.1. Middle East Concussion Market Overview
  • 28.2. Middle East Concussion Market, Segmentation By Assessment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Concussion Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Concussion Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Concussion Market

  • 29.1. Africa Concussion Market Overview
  • 29.2. Africa Concussion Market, Segmentation By Assessment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Concussion Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Concussion Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Concussion Market Competitive Landscape And Company Profiles

  • 30.1. Concussion Market Competitive Landscape
  • 30.2. Concussion Market Company Profiles
    • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis

31. Concussion Market Other Major And Innovative Companies

  • 31.1. Viatris Inc.
  • 31.2. Zydus Lifesciences Ltd.
  • 31.3. Integra LifeSciences Corporation
  • 31.4. Nihon Kohden Corporation
  • 31.5. Raumedic AG
  • 31.6. Lupin Limited
  • 31.7. NeuroPace Inc.
  • 31.8. Compumedics Limited
  • 31.9. NeuroLogica Corporation
  • 31.10. Neural Analytics Inc.
  • 31.11. NovaSignal Corp.
  • 31.12. Back Bay Life Science Advisors
  • 31.13. BrainScope Company Inc.
  • 31.14. Neuro Kinetics Inc.
  • 31.15. ImPACT Applications Inc.

32. Global Concussion Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Concussion Market

34. Recent Developments In The Concussion Market

35. Concussion Market High Potential Countries, Segments and Strategies

  • 35.1 Concussion Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Concussion Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Concussion Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦